Patricia Rodriguez

Title: Innovations by Patricia Rodriguez in Cardiac Function Regulation

Introduction

Patricia Rodriguez is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cardiac function regulation through her innovative research and inventions. With a total of 2 patents, her work focuses on novel nucleic acids and their applications in treating cardiac conditions.

Latest Patents

Rodriguez's latest patents include a method for decreasing cardiac issues using a nucleic acid molecule encoding a variant phosphatase inhibitor-1. This invention relates to novel nucleic acids that encode mutant forms of Inhibitor Protein-1 (I-1), which have altered phosphorylation sites of PKC-α. The invention also encompasses methods for regulating cardiac contractility and function, as well as treatments for cardiomyopathy and heart failure. Additionally, her patent on phosphatase inhibitor protein-1 as a regulator of cardiac function further explores these novel nucleic acids and their potential therapeutic applications.

Career Highlights

Patricia Rodriguez is affiliated with the University of Cincinnati, where she continues her research and development in the field of cardiac health. Her work has garnered attention for its potential impact on treating heart-related ailments.

Collaborations

Rodriguez collaborates with notable colleagues, including Evangelia Kranias and Bryan Mitton, who contribute to her research endeavors.

Conclusion

Patricia Rodriguez's innovative work in cardiac function regulation showcases her dedication to advancing medical science. Her patents reflect a commitment to improving treatments for heart conditions, making her a valuable contributor to the field.